Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical trifarotene 0.005% vs tretinoin 0.05% for acne vulgaris
TCTR20260607001Phase 4Not yet recruiting
- Sponsor
- Salinee Rojhirunsakool
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trifarotene, tretinoin in acne vulgaris, sponsored by Salinee Rojhirunsakool. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
trifarotenetretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20260607001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260607001.